APVOVSGOSS• 7 Days (Normalized)
APVO vs GOSS (Aptevo Therapeutics Inc. vs Gossamer Bio Inc.)
Showing Closing Date Range from Sep, 07 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
APVO Performance $1.8
-4.26%
Aptevo Therapeutics Inc.
Normalized Baseline0.00%
GOSS Performance $10.7
-25.69%
Gossamer Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin APVO LEADS
+21.43%
APVO outperforming by 21.43%
APVOGOSS
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
APVO GOSS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | APVO Price | APVO Gain (%) | GOSS Price | GOSS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $1.80 | -4.26% | $10.70 | -25.69% | +21.43% |
| Sep 11, 2026 | $1.82 | -3.19% | $10.73 | -25.49% | +22.30% |
| Sep 10, 2026 | $1.83 | -2.66% | $11.36 | -21.11% | +18.45% |
| Sep 09, 2026 | $1.85 | -1.86% | $12.80 | -11.11% | +9.25% |
| Sep 08, 2026 | $1.88 | +0.00% | $14.40 | +0.00% | +0.00% |